About this trial
Observational study in physicians regarding their adherence to clinical guidelines (by American Diabetes Association 2025) for the management of type 2 diabetes mellitus and obesity via questionnaire
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Physicians practicing in Greece
Physicians treating patients with Diabetes Mellitus type 2 and Obesity
Disqualifiers
Non Physicians
Trial population
The target population consisted of physicians in Greece who provide care for patients with type two Diabetes Mellitus and obesity, including General Practitioners, Internal Medicine Specialists, Endocrinologists, Resident Doctors and Rural Service Doctors.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Questionnaire regarding the adherence to American Diabetes Association
Other interventionA questionnaire titled "Physicians' adherence to the current clinical guidelines for the management of patients with type two diabetes mellitus and obesity" was formed, consisting of two sections and 18 closed-ended questions in total. Τhe first part focused on demographics and included four questions, while the second addressed the frequency of adherence to clinical guidelines and consisted of fourteen questions. A 5-point Likert scale, ranging from 'never', 'rarely' (1 - 2 times a month), 'sometimes' (1 - 2 times a week), 'frequently' (3 - 4 times a week) to 'always' (everyday), was used for the 14 questions, aiming to quantify the frequency of implementation. An introductory statement accompanied the questionnaire to provide study details and guarantee anonymous responses.
Treatment groups
Trial outcomes
Primary outcomes
Questionnaire
A questionnaire titled "Physicians' adherence to the current clinical guidelines for the management of patients with type two diabetes mellitus and obesity" was formed, consisting of two sections and 18 closed-ended questions in total. Τhe first part focused on demographics and included four questions, while the second addressed the frequency of adherence to clinical guidelines and consisted of fourteen questions. A 5-point Likert scale, ranging from 'never', 'rarely' (1 - 2 times a month), 'sometimes' (1 - 2 times a week), 'frequently' (3 - 4 times a week) to 'always' (everyday), was used for the 14 questions, aiming to quantify the frequency of implementation. An introductory statement accompanied the questionnaire to provide study details and guarantee anonymous responses
Sponsors and contacts
Click on the lead sponsor to view all of their trials.